29913-84-6

Basic information

• Product Name: S-Methyl-D-penicillaMine
• Synonyms: S-Methyl-D-penicillaMine
• CAS NO: 29913-84-6
• Molecular Formula: C6H13NO2S
• Molecular Weight: 163.23792
• Product Categories: Amino Acids & Derivatives, Metabolites & Impurities, Sulfur & Selenium Compounds
• Mol File: 29913-84-6.mol
• Article Data: 3

Chemical Properties

• Melting Point: 281-282 °C
• Boiling Point: 278.5±35.0 °C(Predicted)
• Appearance: /
• Density: 1.163±0.06 g/cm3(Predicted)
• Storage Temp.: Refrigerator
• Solubility: Aqueous Base (Slightly), Water (Slightly)
• PKA: 2.13±0.12(Predicted)
• CAS DataBase Reference: S-Methyl-D-penicillaMine(CAS DataBase Reference)
• NIST Chemistry Reference: S-Methyl-D-penicillaMine(29913-84-6)
• EPA Substance Registry System: S-Methyl-D-penicillaMine(29913-84-6)

Safety Data

• Hazardous Substances Data: 29913-84-6(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 29913-84-6 differently. You can refer to the following data:
1. S-Methyl-D-penicillamine is a biochemical transformed metabolite of D-Penicillamine (P223000). Studies show that elevated levels of S-Methyl-D-penicillamine were excreted in the urine of patients with Parkinson's and Motor Neuron Disease patients.
2. S-Methyl-D-penicillamine is a biochemical transformed metabolite of D-Penicillamine (P223000). Studies show that elevated levels of S-Methyl-D-penicillamine were excreted in the urine of patients with Parkinson''s and Motor Neuron Disease patients.

Upstream product

• 52-67-5 3,3-dimethyl-D-cysteine 
• 74-88-4 methyl iodide 

Relevant articles and documents

The species- and site-specific acid-base properties of penicillamine and its homodisulfide

Penicillamine, penicillamine disulfide and 4 related compounds were studied by 1H NMR-pH titrations and case-tailored evaluation methods. The resulting acid-base properties are quantified in terms of 14 macroscopic and 28 microscopic protonation constants and the concomitant 7 interactivity parameters. The species- and site-specific basicities are interpreted by means of inductive and shielding effects through various intra- and intermolecular comparisons. The thiolate basicities determined this way are key parameters and exclusive means for the prediction of thiolate oxidizabilities and chelate forming properties in order to understand and influence chelation therapy and oxidative stress at the molecular level.

Acyclic metalloprotease inhibitors

The invention provides compounds of formula as described in the claims, or an optical isomer, diastereomer or enantiomer thereof, or a pharmaceutically-acceptable salt, or biohydrolyzable amide, ester, or imide thereof are useful as inhibitors of metallop